diffuse alveolar hemorrhage syndrom katarina osolnik university clinic of respiratory and allergic...
TRANSCRIPT
![Page 1: DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM Katarina Osolnik University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia Portorož, May 8th 2009](https://reader034.vdocuments.site/reader034/viewer/2022051618/56649c9e5503460f9495e9f0/html5/thumbnails/1.jpg)
DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM
Katarina OsolnikUniversity Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia
Portorož, May 8th 2009
![Page 2: DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM Katarina Osolnik University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia Portorož, May 8th 2009](https://reader034.vdocuments.site/reader034/viewer/2022051618/56649c9e5503460f9495e9f0/html5/thumbnails/2.jpg)
DIFFUSE ALVEOLAR HEMORRHAGE
• acute, life-threatening event
• repeated episodes can lead to:
• organizing pneumonia
• collagen deposition in small airways
• fibrosis
![Page 3: DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM Katarina Osolnik University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia Portorož, May 8th 2009](https://reader034.vdocuments.site/reader034/viewer/2022051618/56649c9e5503460f9495e9f0/html5/thumbnails/3.jpg)
DIFFUSE ALVEOLAR HEMORRHAGE
• Wegener granulomatosis
• microscopic polyangiitis
• Goodpasture syndrome
• connective tissue disorders
• antiphospholipid antibody sy
• infectious or toxic exposures
• neoplastic conditions
![Page 4: DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM Katarina Osolnik University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia Portorož, May 8th 2009](https://reader034.vdocuments.site/reader034/viewer/2022051618/56649c9e5503460f9495e9f0/html5/thumbnails/4.jpg)
CAUSES OF DIFFUSE ALVEOLAR HEMORRHAGE
• vasculitis or capillaritis
• pulmonary haemorrhage without capillaritis or vasculitis (»bland« pulmonary haemorrhage)
• alveolar bleeding associated with another process or condition
![Page 5: DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM Katarina Osolnik University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia Portorož, May 8th 2009](https://reader034.vdocuments.site/reader034/viewer/2022051618/56649c9e5503460f9495e9f0/html5/thumbnails/5.jpg)
CLINICAL MANIFESTATIONSAcute or subacute (present for less than a
week)
• dyspnea,
• cough,
• fever,
• haemoptysis are the most common clinical manifestations of DAH.
*Haemoptysis may be absent at time of presentation in up to a third of patients.
![Page 6: DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM Katarina Osolnik University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia Portorož, May 8th 2009](https://reader034.vdocuments.site/reader034/viewer/2022051618/56649c9e5503460f9495e9f0/html5/thumbnails/6.jpg)
DIAGNOSTIC EVALUATION
Chest X-ray
• diffuse, bilateral consolidation or ground-glass opacities due to alveolar filling
• distributed in the perihilar regions, sparing the apices and costophrenic angels
![Page 7: DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM Katarina Osolnik University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia Portorož, May 8th 2009](https://reader034.vdocuments.site/reader034/viewer/2022051618/56649c9e5503460f9495e9f0/html5/thumbnails/7.jpg)
DIAGNOSTIC EVALUATION
HRCT• better evaluate the
extent of disease • more sensitive in
identifying ground-glass opacities, but not more specific
![Page 8: DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM Katarina Osolnik University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia Portorož, May 8th 2009](https://reader034.vdocuments.site/reader034/viewer/2022051618/56649c9e5503460f9495e9f0/html5/thumbnails/8.jpg)
DIAGNOSTIC EVALUATION
Laboratory tests• anemia, leukocytosis• ESR, CRP• blood urea and serum
creatinine, abnormal findings of urin analysis in pulmonary-renal sy
• anti-GBM, ANCA, C3 and C4, anti-ds-DNA, antiphospholipid Ab
Pulmonary function test
• increased diffusing capacity
• restrictive changes • obstructive changes
![Page 9: DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM Katarina Osolnik University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia Portorož, May 8th 2009](https://reader034.vdocuments.site/reader034/viewer/2022051618/56649c9e5503460f9495e9f0/html5/thumbnails/9.jpg)
DIAGNOSTIC EVALUATION
Bronchoscopy
• to document alveolar hemorrhage by BAL
• to exclude airway sources of bleeding
• to exclude an associated infection
Within the first 48 hours of symptoms the diagnostic yield is higher!
![Page 10: DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM Katarina Osolnik University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia Portorož, May 8th 2009](https://reader034.vdocuments.site/reader034/viewer/2022051618/56649c9e5503460f9495e9f0/html5/thumbnails/10.jpg)
BAL
• is the method of choice
• by showing free red blood cells and hemosiderin-laden, iron-positive macrophages
![Page 11: DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM Katarina Osolnik University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia Portorož, May 8th 2009](https://reader034.vdocuments.site/reader034/viewer/2022051618/56649c9e5503460f9495e9f0/html5/thumbnails/11.jpg)
BAL WITH IRON +AM GOLNIK 2004-2009
(64+/84staining samples)
• vasculitis or capillaritis 29%
• pulmonary haemorrhage without capillaritis or vasculitis (»bland« pulmonary haemorrhage) 18%
• alveolar bleeding associated with another process or condition 39% ...................................................................
• pneumoconiosis 14%
![Page 12: DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM Katarina Osolnik University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia Portorož, May 8th 2009](https://reader034.vdocuments.site/reader034/viewer/2022051618/56649c9e5503460f9495e9f0/html5/thumbnails/12.jpg)
BAL WITH IRON +AM GOLNIK 2004-2009
vasculitis or capillaritis:
• 58% sistemic vasculitis
• 42% connective tissue disorders
pulmonary haemorrhage without capillaritis or vasculitis:
• 66% drugs• 17% infective
endocarditis
![Page 13: DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM Katarina Osolnik University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia Portorož, May 8th 2009](https://reader034.vdocuments.site/reader034/viewer/2022051618/56649c9e5503460f9495e9f0/html5/thumbnails/13.jpg)
BAL WITH IRON +AM GOLNIK 2004-2009
alveolar bleeding associated with another process or condition:
• 48% infections
• 32% sarcoidosis
• 20% malignant conditions
![Page 14: DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM Katarina Osolnik University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia Portorož, May 8th 2009](https://reader034.vdocuments.site/reader034/viewer/2022051618/56649c9e5503460f9495e9f0/html5/thumbnails/14.jpg)
TREATMENT OF DAH
• combination of treatment autoimmune destruction of the alveolare capillary membrane and the underlaying condition
• immunosupresive agents are the mainstay of therapy, especially if DAH is associated with systemic or pulmonary vasculitis, Goodpasture syndrome or conective tissue disorders
• treatment of small vessel vasculitis of the lung is largely the same, regardless of aetiology or whether it is isolated
to the lung or a component of a systemic disease
![Page 15: DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM Katarina Osolnik University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia Portorož, May 8th 2009](https://reader034.vdocuments.site/reader034/viewer/2022051618/56649c9e5503460f9495e9f0/html5/thumbnails/15.jpg)
TREATMENT OF DAH
Immunosupresive agents• Methylprednisolone and• Cyclophosphamide are the mainstay of therapy. • Plasmapheresis - clinical benefit in Goodpasture
syndrome • Recombinant activated human factor VII-
successful in several case reports of treating alveolar hemorrhage due to allogenic hematopoietic stem cell transplantation, ANCA associated vascullitis, SLE or antiphospholipid syndrome.
![Page 16: DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM Katarina Osolnik University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia Portorož, May 8th 2009](https://reader034.vdocuments.site/reader034/viewer/2022051618/56649c9e5503460f9495e9f0/html5/thumbnails/16.jpg)
TREATMENT OF DAH-other possible management measures: • supplemental oxygen, • bronchodilators, • reversal of any coagulopathy, • intubation with bronchial tamponade,• protective strategies for the less involved lung,• mechanical ventilation
should be done in the course of the disease if they are needed.
![Page 17: DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM Katarina Osolnik University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia Portorož, May 8th 2009](https://reader034.vdocuments.site/reader034/viewer/2022051618/56649c9e5503460f9495e9f0/html5/thumbnails/17.jpg)
CONCLUSION
• DAH can be a catastrophic illness if recognition and treatment are delayed.
• Diagnosis is often aided by other systemic findings, associated illnes and serological results.
• Patients with unexplained isolated DAH should undergo a lung biopsy with immunofluorescent studies and routine histological tests.
• During therapy close monitoring, due to potential complications of treatment and the possibility to relapses, is needed.